General Information
Drug ID
DR01473
Drug Name
Zoledronic acid
Synonyms
Aclasta; Reclast; ZOL; Zometa; Novartis brand of zoledronic acid; Zoledronic acid; Zometa Concentrate; Bisphosphonate 3; CGP 42446; CGP 42446A; Aclasta (TN); CGP 42'446; CGP-42446; KS-1132; Reclast (TN); Zoledronic acid (INN); Zoledronic acid [USAN:INN]; Zomera (TN); Zometa (Novartis); Zometa (TN); CGP-42'446; Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid; [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid); (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid; (1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate; 2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid; 2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
Drug Type
Small molecular drug
Indication Paget's disease [ICD11: FB85] Approved [1]
Therapeutic Class
Bone Density Conservation Agents
Structure
3D MOL 2D MOL
Formula
C5H10N2O7P2
Canonical SMILES
C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
InChI
InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14)
InChIKey
XRASPMIURGNCCH-UHFFFAOYSA-N
CAS Number
CAS 118072-93-8
Pharmaceutical Properties Molecular Weight 272.09 Topological Polar Surface Area 153
Heavy Atom Count 16 Rotatable Bond Count 4
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 8
XLogP
-4.3
PubChem CID
68740
PubChem SID
536160 , 6436371 , 7891233 , 7980916 , 8192311 , 10318362 , 10318375 , 10318390 , 10318944 , 11528905 , 14824151 , 25819963 , 29215499 , 29215500 , 43125267 , 46507310 , 46513035 , 50473172 , 53788750 , 53801236 , 56311814 , 56436259 , 56479320 , 57317038 , 81092860 , 85174457 , 87457600 , 89736141 , 92308965 , 92712542 , 93166450 , 93167152 , 96025372 , 99343600 , 99343604 , 99437087 , 99455519 , 103240897 , 104342928 , 109692939 , 117626547 , 118048654 , 124757161 , 125163965 , 125338822 , 126592903 , 126625470 , 126656631 , 126667014 , 127324075
ChEBI ID
ChEBI:46557
TTD Drug ID
D0VM2L
DT(s) Transporting This Drug MRP1 Transporter Info Multidrug resistance-associated protein 1 Substrate [2]
References
1 zoledronic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein-1 dependent way: an in vitro study. Cell Biol Int. 2006 Mar;30(3):278-82.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.